SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Care-plan review) — Ulysses S. Grant

PatientUlysses S. Grant
Date of birth1964-04-27
IdentifiersMRN HR-NI002-SYN; SSN (made up) 000-02-9416
Document date2026-10-22
AuthorCorinne Batiste, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Primary care review three weeks after chemoradiation. [S]

History of Present Illness

Mr. Grant returns three weeks after finishing chemoradiation, directed by the head and neck oncology team, for p16-negative squamous cell carcinoma of the right tonsillar pillar. His throat pain has eased to 3 of 10. He takes the acetaminophen solution once or twice a day and rarely needs the lidocaine rinse. His mouth is dry and food tastes muted, so he sips water with every mouthful. He eats soft foods with two supplement drinks a day and did not need a feeding tube. He weighs 71.0 kg, 7 kg below his weight at intake. He has smoked no cigars since mid-July and continues varenicline 1 mg twice daily without side effects. His energy is slowly returning and he writes for two to three hours a day. He has had no fever, bleeding, choking, or new lumps in the neck, and no change in his hearing. He uses fluoride gel in trays each night, as the dentist advised before radiation. [S]

ElementDetail
TreatmentChemoradiation completed three weeks ago
Pain3 of 10; acetaminophen once or twice a day; lidocaine rinse rarely
Late effectsDry mouth and muted taste; no choking
Weight and nutrition71.0 kg, 9 percent below intake; no feeding tube needed
TobaccoNo cigars since mid-July; varenicline continued
FunctionEnergy returning; writing two to three hours a day

Review of Systems

SystemResultFinding
ConstitutionalPositiveFatigue, improving; no fever or night sweats
Ears, nose, mouth, and throatPositiveDry mouth, muted taste, and throat pain 3 of 10; no hearing change or ear pain
RespiratoryNegativeNo cough, choking with liquids, or breathlessness
GastrointestinalNegativeNo nausea or vomiting; bowels regular
IntegumentaryPositiveDarkened, dry skin on the neck from radiation, healing
HematologicNegativeNo bruising or bleeding
PsychiatricNegativeMood steady; PHQ-2 score 1

7 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet, one tablet daily for three days, then one tablet twice dailyOne tablet by mouth daily for three days, then twice dailyOral route2026-07-07 to 2026-07-21completedS
Varenicline 1 mg oral tablet, one tablet twice dailyOne tablet by mouth twice daily after mealsOral route2026-07-21activeS
Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain20 mL by mouth every 6 hours as needed for pain; no more than 3,000 mg a dayOral route2026-07-07activeS
Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat painSwish 15 mL and spit up to every 3 hours as needed, no more than 8 doses a day; do not eat or drink for 60 minutes after useTopical route2026-07-07activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-22Body height173cmS
2026-10-22Body weight71kgS
2026-10-22Body mass index (BMI) [Ratio]23.7kg/m2S
2026-10-22Systolic blood pressure118mm[Hg]S
2026-10-22Diastolic blood pressure72mm[Hg]S
2026-10-22Heart rate84/minS
2026-10-22Respiratory rate16/minS
2026-10-22Body temperature36.9CelS
2026-10-22Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-22Hemoglobin [Mass/volume] in Blood11.9g/dL13.2-16.6 g/dLLowS
2026-10-22Leukocytes [#/volume] in Blood by Automated count3.610*3/uL4-11 10*3/uLLowS
2026-10-22Platelets [#/volume] in Blood by Automated count16810*3/uL150-400 10*3/uLNormalS
2026-10-22Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-10-22Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-10-22Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
2026-10-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M74mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-22Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-10-22Albumin [Mass/volume] in Serum or Plasma3.3g/dL3.5-5 g/dLLowS
2026-10-22Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-10-22Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S

Physical Exam

Vital signs recorded on 2026-10-22; see the Vital Signs section. [S]

SystemFinding
GeneralThinner, alert, and in good spirits
OropharynxDry mucosa; the treated right tonsillar area is healing, with no ulcer or visible mass
NeckHealing radiation skin changes; firm tissue on the right with no discrete node
LungsClear
HeartRegular rhythm; no murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Squamous cell carcinoma of the right tonsillar pillar, p16-negative, suspected at presentation and confirmed by biopsy at the otolaryngology visit; linked to the documented 1885 diagnosisactiveconfirmed C09.1S — Synthetic diagnosis in the modern episode; the 1884-1885 findings remain D.
Nicotine dependence, cigars, about ten a day for more than forty yearsactiveconfirmed F17.290S — Synthetic modern diagnosis linked to documented heavy cigar smoking.
Painful swallowing with oropharyngeal dysphagia from the tonsillar tumoractiveconfirmed R13.12S — Synthetic symptom diagnosis echoing the documented painful swallowing.
Unintended weight loss from painful swallowing, about 2 kg before presentationactiveconfirmed R63.4S — Synthetic finding from the measured weights.
Acute viral bronchitis after a head cold during the cancer workup, resolved without antibioticsresolvedconfirmed J20.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryCBC, basic metabolic panel, and albuminBefore and after treatmentCompleted todayHemoglobin 11.9 and white count 3.6, both low after treatment; platelets 168; sodium 136, potassium 4.0, creatinine 1.12, eGFR 74, glucose 94; albumin 3.3, low
LaboratoryRepeat CBC and basic metabolic panelUntil counts and kidney function recoverDueIn four to six weeks
LaboratoryTSHEvery 6 to 12 months after neck radiationDueBaseline 1.8 mIU/L; first check about six months after treatment
ExaminationHistory and head and neck examinationEvery 1 to 3 months in the first year after treatmentCompleted todayNo ulcer, mass, or discrete neck node; laryngoscopy at the head and neck oncology follow-up
ReferralHead and neck oncology follow-up with laryngoscopyEvery 1 to 3 months in the first year after treatmentDueFirst post-treatment review with the head and neck team in the coming weeks
ImagingPost-treatment PET/CTAt least 12 weeks after treatment, within 6 monthsDueAbout nine weeks from now, arranged by the head and neck team
ImagingLung cancer screening with low-dose CTAnnually for eligible current and former smokersNot indicatedScreening eligibility is defined by cigarette pack-years, and his tobacco use was cigars; the post-treatment PET/CT includes the chest
ExaminationWeightEvery visitCompleted today71.0 kg, 9 percent below baseline; goal of less than 10 percent loss met
SurveyThroat pain score (0-10)Every visitCompleted today3 of 10
SurveyDepression screen (PHQ-2)Every primary care visit after the diagnosisCompleted todayScore 1
SurveyPHQ-9 after a PHQ-2 score of 2 or moreWhenever the PHQ-2 is 2 or moreDeferredThe PHQ-2 of 2 at the pre-treatment visit was not followed by a PHQ-9, a deviation from the protocol. Today's PHQ-2 is 1 and he reports a steady mood, so no harm is evident; a PHQ-9 will follow any PHQ-2 of 2 or more
ReferralSpeech-language pathology swallowing reviewAfter treatment and as neededReferredReferred for a post-treatment swallowing assessment
ReferralDietitian follow-upDuring recoveryReferredTo help him regain weight; albumin 3.3
ReferralDental review with daily fluorideEvery 6 months after neck radiationUp to dateDental evaluation done before radiation; fluoride trays nightly
ExaminationHearing and ear symptomsEach follow-up visitCompleted todayNo hearing change or ear pain
Self-managementTobacco use status and cessation counselingEvery visitCompleted todayNo cigars for about fourteen weeks; relapse-prevention counseling given
Medication safetyVarenicline tolerance: nausea, sleep, mood, and behaviorEach visit during treatmentCompleted todayNo side effects; continued to complete about 24 weeks in all
Medication safetyInfluenza vaccineEvery seasonCompleted todayGiven today

Goal progress:

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016)

Follow-up: Head and neck oncology follow-up in the coming weeks and post-treatment PET/CT about 12 weeks after treatment. Primary care visit in four to six weeks with a CBC and basic metabolic panel. [S]